HOPPER JONATHAN MARK (Chief Medical Officer) sold 5.5% of their position (4.38K shares) of VERICEL CORP on the open market
Open‑market sale worth $153.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2026ACC: 0001140361-26-023988
Officer· Chief Medical Officer
Since Feb 2020
+4.38K
Net shares
Net buyer
$153.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.75K acquired · 4.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.38K
Price / share
$16.66
Trade value
$72.89K
% of position
5.8%
6/2/2026
75.75K→80.13K
Common Stock
Direct
Shares
−4.38K
Price / share
$35.00
Trade value
$153.13K
% of position
5.5%
6/2/2026
80.13K→75.75K
Total
Net shares
+0.00
Net value
-$80.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | M · Option Exercise | +4.38K | $16.66 | $72.89K | 5.8% | 75.75K | 80.13K |
| Common Stock Direct | 6/2/2026 | S · Sale | −4.38K | $35.00 | $153.13K | 5.5% | 80.13K | 75.75K |
| Total | +0.00 | -$80.24K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.38K shares
Shares
+4.38K
Strike price
16.66
Held after
1.63K
Exercisable
—
6/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.38K shares | 6/2/2026 | M · Option Exercise | +4.38K | 16.66 | — | 1.63K |